Alpha Tau Medical Ltd. announced its ordinary shares will be included in the TA-90 and TA-125 indices of the Tel Aviv Stock Exchange starting November 5, 2026. This inclusion places Alpha Tau among the largest and most prominent companies on the TASE, increasing its visibility to Israeli institutional investors and likely boosting trading liquidity. Alpha Tau is one of only three biomedical companies in the TA-125, enhancing its profile as it expands its innovative alpha-radiation cancer therapy, Alpha DaRT. The move is expected to broaden Alpha Tau’s shareholder base and support its growth in both Israeli and global markets.
Alpha Tau Medical's inclusion in the TA-90 and TA-125 indices provides context for readers interested in healthcare sector movements. For readers following health stocks, here is Pluang's market snapshot as of Oct 29, 2026 22:21 WIB: out of 150 priced health-sector US stocks, 116 rose and 34 fell. Notable movers include TDOC at USD 8.81 with a 28.05% increase, ALNY at USD 190.23 down 18.15%, and MESO at USD 15.59 up 16.43%.
The inaugural SportsTech Breakthrough Awards recognized leading companies and technologies advancing sports technology globally. Winners span categories like athlete performance, wearables, AI analytics, fan engagement, and smart stadium solutions, h...
The global Industrial Control System (ICS) Security Market is projected to grow from $17.91 billion in 2026 to $38.48 billion by 2031, at a CAGR of 16.5%. This growth is driven by rising cyberattacks targeting critical infrastructure and the increasi...
AdvantageLumber.com has introduced Sketch-A-Deck, a free online software that simplifies deck design for homeowners and contractors. The tool allows users to draw custom deck layouts, attach them to their homes, and generate build-ready plans with de...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
